BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 827378 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCOCC1 InChI=1S/C20H19F3N4O3/c1-29-17-10-15-12(11-27(26-15)13-5-7-30-8-6-13)9-16(17)25-19(28)14-3-2-4-18(24-14)20(21,22)23/h2-4,9-11,13H,5-8H2,1H3,(H,25,28) CLTMZWHUHMFOTM-UHFFFAOYSA-N 414419 N-[6-Methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 1 Interleukin-1 receptor-associated kinase 4 Homo sapiens 3.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414419&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377462 433914477 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827379 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCNCC1 InChI=1S/C20H20F3N5O2/c1-30-17-10-15-12(11-28(27-15)13-5-7-24-8-6-13)9-16(17)26-19(29)14-3-2-4-18(25-14)20(21,22)23/h2-4,9-11,13,24H,5-8H2,1H3,(H,26,29) VKFRWIYGVBBMTK-UHFFFAOYSA-N 414421 N-[6-Methoxy-2-(piperidin-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 2 Interleukin-1 receptor-associated kinase 4 Homo sapiens 1.000 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414421&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377454 433914479 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827380 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(CC(F)(F)F)CC1 InChI=1S/C22H21F6N5O2/c1-35-18-10-16-13(11-33(31-16)14-5-7-32(8-6-14)12-21(23,24)25)9-17(18)30-20(34)15-3-2-4-19(29-15)22(26,27)28/h2-4,9-11,14H,5-8,12H2,1H3,(H,30,34) VODBCWCKDVLHQI-UHFFFAOYSA-N 414422 N-{6-Methoxy-2-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 3 Interleukin-1 receptor-associated kinase 4 Homo sapiens 7.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414422&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377323 433914480 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827381 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(C)CC1 InChI=1S/C21H22F3N5O2/c1-28-8-6-14(7-9-28)29-12-13-10-17(18(31-2)11-16(13)27-29)26-20(30)15-4-3-5-19(25-15)21(22,23)24/h3-5,10-12,14H,6-9H2,1-2H3,(H,26,30) XVWGINSVZGMTOB-UHFFFAOYSA-N 414423 N-[6-Methoxy-2-(1-methylpiperidin-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 4 Interleukin-1 receptor-associated kinase 4 Homo sapiens 1.000 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414423&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377410 433914481 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827382 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(CC1)C(=O)CO InChI=1S/C22H22F3N5O4/c1-34-18-10-16-13(11-30(28-16)14-5-7-29(8-6-14)20(32)12-31)9-17(18)27-21(33)15-3-2-4-19(26-15)22(23,24)25/h2-4,9-11,14,31H,5-8,12H2,1H3,(H,27,33) GIEFYDDOCUUGGJ-UHFFFAOYSA-N 414424 N-[2-(1-Glycoloylpiperidin-4-yl)-6-methoxy-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 5 Interleukin-1 receptor-associated kinase 4 Homo sapiens 2.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414424&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377333 433914482 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827383 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(CC1)C1CCN(C)CC1 InChI=1S/C26H31F3N6O2/c1-33-10-6-18(7-11-33)34-12-8-19(9-13-34)35-16-17-14-22(23(37-2)15-21(17)32-35)31-25(36)20-4-3-5-24(30-20)26(27,28)29/h3-5,14-16,18-19H,6-13H2,1-2H3,(H,31,36) MFRHRXMPIJKZLY-UHFFFAOYSA-N 414428 N-[6-Methoxy-2-(1′-methyl-1,4′-bipiperidin-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 6 Interleukin-1 receptor-associated kinase 4 Homo sapiens 2.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414428&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377437 433914486 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827384 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(CC1)S(=O)(=O)NC(C)=O InChI=1S/C22H23F3N6O5S/c1-13(32)29-37(34,35)30-8-6-15(7-9-30)31-12-14-10-18(19(36-2)11-17(14)28-31)27-21(33)16-4-3-5-20(26-16)22(23,24)25/h3-5,10-12,15H,6-9H2,1-2H3,(H,27,33)(H,29,32) ZWENCMCRNRFCPW-UHFFFAOYSA-N 414429 N-{2-[1-(Acetylsulphamoyl)piperidin-4-yl]-6-methoxy-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 8 Interleukin-1 receptor-associated kinase 4 Homo sapiens 8.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414429&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377579 433914487 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827385 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(CCN(C)C)CC1 InChI=1S/C24H29F3N6O2/c1-31(2)11-12-32-9-7-17(8-10-32)33-15-16-13-20(21(35-3)14-19(16)30-33)29-23(34)18-5-4-6-22(28-18)24(25,26)27/h4-6,13-15,17H,7-12H2,1-3H3,(H,29,34) NDABOOUWFLKWNO-UHFFFAOYSA-N 414432 N-(2-{1-[2-(Dimethylamino)ethyl]piperidin-4-yl}-6-methoxy-2H-indazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 9 Interleukin-1 receptor-associated kinase 4 Homo sapiens 1.000 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414432&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377416 433914490 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827386 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(CC1)C1COC1 InChI=1S/C23H24F3N5O3/c1-33-20-10-18-14(11-31(29-18)15-5-7-30(8-6-15)16-12-34-13-16)9-19(20)28-22(32)17-3-2-4-21(27-17)23(24,25)26/h2-4,9-11,15-16H,5-8,12-13H2,1H3,(H,28,32) SEIDWDFWTSKYGD-UHFFFAOYSA-N 414433 N-{6-Methoxy-2-[1-(oxetan-3-yl)piperidin-4-yl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 10 Interleukin-1 receptor-associated kinase 4 Homo sapiens 3.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414433&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377341 433914491 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827387 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCS(=O)(=O)CC1 InChI=1S/C20H19F3N4O4S/c1-31-17-10-15-12(11-27(26-15)13-5-7-32(29,30)8-6-13)9-16(17)25-19(28)14-3-2-4-18(24-14)20(21,22)23/h2-4,9-11,13H,5-8H2,1H3,(H,25,28) BQCCCKDTGFNOHN-UHFFFAOYSA-N 414434 N-[2-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-6-methoxy-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 11 Interleukin-1 receptor-associated kinase 4 Homo sapiens 3.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414434&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137522934 433914492 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827388 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCS(=O)CC1 InChI=1S/C20H19F3N4O3S/c1-30-17-10-15-12(11-27(26-15)13-5-7-31(29)8-6-13)9-16(17)25-19(28)14-3-2-4-18(24-14)20(21,22)23/h2-4,9-11,13H,5-8H2,1H3,(H,25,28) SJQQCUQONPMIOD-UHFFFAOYSA-N 414435 US10435396, Example 12::rac-N-[6-Methoxy-2-(1-oxidotetrahydro-2H-thiopyran-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide Interleukin-1 receptor-associated kinase 4 Homo sapiens 2.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414435&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377405 433914493 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827389 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(CCO)CC1 InChI=1S/C22H24F3N5O3/c1-33-19-12-17-14(13-30(28-17)15-5-7-29(8-6-15)9-10-31)11-18(19)27-21(32)16-3-2-4-20(26-16)22(23,24)25/h2-4,11-13,15,31H,5-10H2,1H3,(H,27,32) CATGVPUKSAZQGO-UHFFFAOYSA-N 414436 N-{2-[1-(2-Hydroxyethyl)piperidin-4-yl]-6-methoxy-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 13 Interleukin-1 receptor-associated kinase 4 Homo sapiens 1.000 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414436&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377456 433914494 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827390 FC(F)(F)c1cccc(n1)C(=O)Nc1cc2cn(nc2cc1OCC1CC1)C1CCS(=O)(=O)CC1 InChI=1S/C23H23F3N4O4S/c24-23(25,26)21-3-1-2-17(27-21)22(31)28-19-10-15-12-30(16-6-8-35(32,33)9-7-16)29-18(15)11-20(19)34-13-14-4-5-14/h1-3,10-12,14,16H,4-9,13H2,(H,28,31) KFRVLUCGIBPBIB-UHFFFAOYSA-N 414437 N-[6-(Cyclopropylmethoxy)-2-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 17 Interleukin-1 receptor-associated kinase 4 Homo sapiens 20.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414437&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377546 433914495 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827391 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)[C@@H]1C[C@@H]2C[C@H]1CN2C InChI=1S/C22H22F3N5O2/c1-29-10-13-6-14(29)8-18(13)30-11-12-7-17(19(32-2)9-16(12)28-30)27-21(31)15-4-3-5-20(26-15)22(23,24)25/h3-5,7,9,11,13-14,18H,6,8,10H2,1-2H3,(H,27,31)/t13-,14-,18+/m0/s1 VALDNGKJYXDJQU-SUNYJGFJSA-N 414439 US10435396, Example 18::rel-N-{6-Methoxy-2-[(1S,4S,5R)-2-methyl-2-azabicyclo[2.2.1]hept-5-yl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide Interleukin-1 receptor-associated kinase 4 Homo sapiens 2.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414439&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137522932 433914497 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827392 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)[C@H]1C[C@@H]2C[C@H]1CN2C InChI=1S/C22H22F3N5O2/c1-29-10-13-6-14(29)8-18(13)30-11-12-7-17(19(32-2)9-16(12)28-30)27-21(31)15-4-3-5-20(26-15)22(23,24)25/h3-5,7,9,11,13-14,18H,6,8,10H2,1-2H3,(H,27,31)/t13-,14-,18-/m0/s1 VALDNGKJYXDJQU-DEYYWGMASA-N 414440 US10435396, Example 19::rel-N-{6-Methoxy-2-[(1S,4S,5S)-2-methyl-2-azabicyclo[2.2.1]hept-5-yl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide Interleukin-1 receptor-associated kinase 4 Homo sapiens 9.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414440&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137522928 433914498 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827393 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCS(=N)(=O)CC1 InChI=1S/C20H20F3N5O3S/c1-31-17-10-15-12(11-28(27-15)13-5-7-32(24,30)8-6-13)9-16(17)26-19(29)14-3-2-4-18(25-14)20(21,22)23/h2-4,9-11,13,24H,5-8H2,1H3,(H,26,29) BHYYVOUMXDQZTR-UHFFFAOYSA-N 414441 US10435396, Example 20 Interleukin-1 receptor-associated kinase 4 Homo sapiens 4.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414441&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137522854 433914499 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827394 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)[C@H]1CCS(=N)(=O)CC1 InChI=1S/C20H20F3N5O3S/c1-31-17-10-15-12(11-28(27-15)13-5-7-32(24,30)8-6-13)9-16(17)26-19(29)14-3-2-4-18(25-14)20(21,22)23/h2-4,9-11,13,24H,5-8H2,1H3,(H,26,29)/t13-,32? BHYYVOUMXDQZTR-DVZDUGKBSA-N 414442 N-[2-(1-Imino-1-oxidohexahydro-1λ4-thiopyran-4-yl)-6-methoxy-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 21 Interleukin-1 receptor-associated kinase 4 Homo sapiens 3.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414442&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137522854 433914500 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827395 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CNC(=O)C1 InChI=1S/C19H16F3N5O3/c1-30-15-7-13-10(9-27(26-13)11-6-17(28)23-8-11)5-14(15)25-18(29)12-3-2-4-16(24-12)19(20,21)22/h2-5,7,9,11H,6,8H2,1H3,(H,23,28)(H,25,29) GZVOOEOYZKUVTO-UHFFFAOYSA-N 414443 N-[6-Methoxy-2-(5-oxopyrrolidin-3-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 22 Interleukin-1 receptor-associated kinase 4 Homo sapiens 13.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414443&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377545 433914501 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827396 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)F)C1CCOCC1 InChI=1S/C20H20F2N4O3/c1-28-18-10-16-12(11-26(25-16)13-5-7-29-8-6-13)9-17(18)24-20(27)15-4-2-3-14(23-15)19(21)22/h2-4,9-11,13,19H,5-8H2,1H3,(H,24,27) IMDFGRCSXWDYBX-UHFFFAOYSA-N 414444 6-(Difluoromethyl)-N-[6-methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]pyridine-2-carboxamide::US10435396, Example 23 Interleukin-1 receptor-associated kinase 4 Homo sapiens 1.000 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414444&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377428 433914502 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827397 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)N1CCOCC1)C1CCOCC1 InChI=1S/C23H27N5O4/c1-30-21-14-19-16(15-28(26-19)17-5-9-31-10-6-17)13-20(21)25-23(29)18-3-2-4-22(24-18)27-7-11-32-12-8-27/h2-4,13-15,17H,5-12H2,1H3,(H,25,29) QKWPDNZEMVIUAB-UHFFFAOYSA-N 414445 N-[6-Methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-6-(morpholin-4-yl)pyridine-2-carboxamide::US10435396, Example 24 Interleukin-1 receptor-associated kinase 4 Homo sapiens 2.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414445&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377441 433914503 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827398 COc1cc2nn(cc2cc1NC(=O)c1csc(C)n1)C1CCOCC1 InChI=1S/C18H20N4O3S/c1-11-19-16(10-26-11)18(23)20-15-7-12-9-22(13-3-5-25-6-4-13)21-14(12)8-17(15)24-2/h7-10,13H,3-6H2,1-2H3,(H,20,23) GISUWYFKUKYENR-UHFFFAOYSA-N 414446 N-[6-Methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-2-methyl-1,3-thiazole-4-carboxamide::US10435396, Example 25 Interleukin-1 receptor-associated kinase 4 Homo sapiens 10.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414446&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377558 433914504 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827399 COc1cc2nn(cc2cc1NC(=O)c1cccc(N)n1)C1CCOCC1 InChI=1S/C19H21N5O3/c1-26-17-10-15-12(11-24(23-15)13-5-7-27-8-6-13)9-16(17)22-19(25)14-3-2-4-18(20)21-14/h2-4,9-11,13H,5-8H2,1H3,(H2,20,21)(H,22,25) RZXXXYJQACAVDT-UHFFFAOYSA-N 414447 6-Amino-N-[6-methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]pyridine-2-carboxamide::US10435396, Example 26 Interleukin-1 receptor-associated kinase 4 Homo sapiens 6.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414447&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377314 433914505 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827400 COc1cc2nn(cc2cc1NC(=O)c1ccnc(n1)C(C)C)C1CCOCC1 InChI=1S/C21H25N5O3/c1-13(2)20-22-7-4-16(23-20)21(27)24-18-10-14-12-26(15-5-8-29-9-6-15)25-17(14)11-19(18)28-3/h4,7,10-13,15H,5-6,8-9H2,1-3H3,(H,24,27) RRDAHNNDQKIFRP-UHFFFAOYSA-N 414456 2-Isopropyl-N-[6-methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]pyrimidine-4-carboxamide::US10435396, Example 27 Interleukin-1 receptor-associated kinase 4 Homo sapiens 111 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414456&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377430 433914514 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827401 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(C)(C)O)C1CCOCC1 InChI=1S/C22H26N4O4/c1-22(2,28)20-6-4-5-16(23-20)21(27)24-18-11-14-13-26(15-7-9-30-10-8-15)25-17(14)12-19(18)29-3/h4-6,11-13,15,28H,7-10H2,1-3H3,(H,24,27) AMSYSGSGVNYOFM-UHFFFAOYSA-N 414457 6-(2-Hydroxypropan-2-yl)-N-[6-methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]pyridine-2-carboxamide::US10435396, Example 28 Interleukin-1 receptor-associated kinase 4 Homo sapiens 3.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414457&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377513 433914515 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827402 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCOC1 InChI=1S/C19H17F3N4O3/c1-28-16-8-14-11(9-26(25-14)12-5-6-29-10-12)7-15(16)24-18(27)13-3-2-4-17(23-13)19(20,21)22/h2-4,7-9,12H,5-6,10H2,1H3,(H,24,27) WEZKKFFVDPFLKI-UHFFFAOYSA-N 414458 N-[6-Methoxy-2-(tetrahydrofuran-3-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 29 Interleukin-1 receptor-associated kinase 4 Homo sapiens 10.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414458&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377401 433914516 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827403 FC(F)(F)c1cccc(n1)C(=O)Nc1cc2cn(nc2cc1Cl)C1CCOCC1 InChI=1S/C19H16ClF3N4O2/c20-13-9-15-11(10-27(26-15)12-4-6-29-7-5-12)8-16(13)25-18(28)14-2-1-3-17(24-14)19(21,22)23/h1-3,8-10,12H,4-7H2,(H,25,28) QRXHGUSVDPFNJN-UHFFFAOYSA-N 414459 N-[6-Chloro-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 30 Interleukin-1 receptor-associated kinase 4 Homo sapiens 47.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414459&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377334 433914517 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827404 FC(F)c1cccc(n1)C(=O)Nc1cc2cn(nc2cc1Cl)C1CCOCC1 InChI=1S/C19H17ClF2N4O2/c20-13-9-16-11(10-26(25-16)12-4-6-28-7-5-12)8-17(13)24-19(27)15-3-1-2-14(23-15)18(21)22/h1-3,8-10,12,18H,4-7H2,(H,24,27) SJUPOPAMQINQOU-UHFFFAOYSA-N 414461 N-[6-Chloro-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-6-(difluoromethyl)pyridine-2-carboxamide::US10435396, Example 31 Interleukin-1 receptor-associated kinase 4 Homo sapiens 22.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414461&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377316 433914519 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827405 CC(C)(O)c1cccc(n1)C(=O)Nc1cc2cn(nc2cc1Cl)C1CCS(=O)(=O)CC1 InChI=1S/C21H23ClN4O4S/c1-21(2,28)19-5-3-4-16(23-19)20(27)24-18-10-13-12-26(25-17(13)11-15(18)22)14-6-8-31(29,30)9-7-14/h3-5,10-12,14,28H,6-9H2,1-2H3,(H,24,27) DARNQLSKIDRYKQ-UHFFFAOYSA-N 414462 N-[6-Chloro-2-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-2H-indazol-5-yl]-6-(2-hydroxypropan-2-yl)pyridine-2-carboxamide::US10435396, Example 32 Interleukin-1 receptor-associated kinase 4 Homo sapiens 34.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414462&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377595 433914520 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827406 COC(=O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCOCC1 InChI=1S/C21H19F3N4O4/c1-31-20(30)14-10-16-12(11-28(27-16)13-5-7-32-8-6-13)9-17(14)26-19(29)15-3-2-4-18(25-15)21(22,23)24/h2-4,9-11,13H,5-8H2,1H3,(H,26,29) JSCSDCWYWCORHO-UHFFFAOYSA-N 414463 Methyl 2-(tetrahydro-2H-pyran-4-yl)-5-({[6-(trifluoromethyl)pyridin-2-yl]carbonyl}amino)-2H-indazole-6-carboxylate::US10435396, Example 33 Interleukin-1 receptor-associated kinase 4 Homo sapiens 11.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414463&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377352 433914521 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827407 CC(C)(O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCOCC1 InChI=1S/C22H23F3N4O3/c1-21(2,31)15-11-17-13(12-29(28-17)14-6-8-32-9-7-14)10-18(15)27-20(30)16-4-3-5-19(26-16)22(23,24)25/h3-5,10-12,14,31H,6-9H2,1-2H3,(H,27,30) CUEUSICNGPOYFM-UHFFFAOYSA-N 414464 N-[6-(2-Hydroxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 34 Interleukin-1 receptor-associated kinase 4 Homo sapiens 6.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414464&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377486 433914522 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827408 CC(C)(O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)[C@H]1CCOC1 InChI=1S/C21H21F3N4O3/c1-20(2,30)14-9-16-12(10-28(27-16)13-6-7-31-11-13)8-17(14)26-19(29)15-4-3-5-18(25-15)21(22,23)24/h3-5,8-10,13,30H,6-7,11H2,1-2H3,(H,26,29)/t13-/m0/s1 KWISQFLSAWNNRM-ZDUSSCGKSA-N 414465 N-{6-(2-Hydroxypropan-2-yl)-2-[(3S)-tetrahydrofuran-3-yl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 36 Interleukin-1 receptor-associated kinase 4 Homo sapiens 28.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414465&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377435 433914523 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827409 CC(C)(O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)[C@@H]1CCOC1 InChI=1S/C21H21F3N4O3/c1-20(2,30)14-9-16-12(10-28(27-16)13-6-7-31-11-13)8-17(14)26-19(29)15-4-3-5-18(25-15)21(22,23)24/h3-5,8-10,13,30H,6-7,11H2,1-2H3,(H,26,29)/t13-/m1/s1 KWISQFLSAWNNRM-CYBMUJFWSA-N 414466 N-{6-(2-Hydroxypropan-2-yl)-2-[(3R)-tetrahydrofuran-3-yl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 38 Interleukin-1 receptor-associated kinase 4 Homo sapiens 31.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414466&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377335 433914524 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827410 CC(C)(O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)[C@H]1CCS(=O)(=O)C1 InChI=1S/C21H21F3N4O4S/c1-20(2,30)14-9-16-12(10-28(27-16)13-6-7-33(31,32)11-13)8-17(14)26-19(29)15-4-3-5-18(25-15)21(22,23)24/h3-5,8-10,13,30H,6-7,11H2,1-2H3,(H,26,29)/t13-/m0/s1 SVXGLJRWMXEQBR-ZDUSSCGKSA-N 414467 N-{2-[(3S)-1,1-Dioxidotetrahydrothiophen-3-yl]-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 41 Interleukin-1 receptor-associated kinase 4 Homo sapiens 16.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414467&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377464 433914525 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827411 CC(C)(O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCS(=O)(=O)CC1 InChI=1S/C22H23F3N4O4S/c1-21(2,31)15-11-17-13(12-29(28-17)14-6-8-34(32,33)9-7-14)10-18(15)27-20(30)16-4-3-5-19(26-16)22(23,24)25/h3-5,10-12,14,31H,6-9H2,1-2H3,(H,27,30) CEWZCLVHRBLCTE-UHFFFAOYSA-N 414468 N-[2-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 44 Interleukin-1 receptor-associated kinase 4 Homo sapiens 5.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414468&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377491 433914526 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827412 CC(C)(O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCNCC1 InChI=1S/C22H24F3N5O2/c1-21(2,32)15-11-17-13(12-30(29-17)14-6-8-26-9-7-14)10-18(15)28-20(31)16-4-3-5-19(27-16)22(23,24)25/h3-5,10-12,14,26,32H,6-9H2,1-2H3,(H,28,31) CXUGRBGCAGUYQX-UHFFFAOYSA-N 414469 N-[6-(2-Hydroxypropan-2-yl)-2-(piperidin-4-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 46 Interleukin-1 receptor-associated kinase 4 Homo sapiens 3.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414469&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377537 433914527 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827413 COc1cc2nn(cc2cc1NC(=O)c1nc(cs1)C(F)(F)F)C1CCOCC1 InChI=1S/C18H17F3N4O3S/c1-27-14-7-12-10(8-25(24-12)11-2-4-28-5-3-11)6-13(14)22-16(26)17-23-15(9-29-17)18(19,20)21/h6-9,11H,2-5H2,1H3,(H,22,26) QAUXJPRZPTXJPT-UHFFFAOYSA-N 414470 N-[6-Methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-4-(trifluoromethyl)-1,3-thiazole-2-carboxamide::US10435396, Example 47 Interleukin-1 receptor-associated kinase 4 Homo sapiens 65.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414470&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137522929 433914528 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827414 COc1cc2nn(cc2cc1NC(=O)c1nc(no1)-c1ccncc1)C1CCOCC1 InChI=1S/C21H20N6O4/c1-29-18-11-16-14(12-27(25-16)15-4-8-30-9-5-15)10-17(18)23-20(28)21-24-19(26-31-21)13-2-6-22-7-3-13/h2-3,6-7,10-12,15H,4-5,8-9H2,1H3,(H,23,28) CVTVEZWIHYHIEG-UHFFFAOYSA-N 414471 N-[6-Methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-3-(pyridin-4-yl)-1,2,4-oxadiazole-5-carboxamide::US10435396, Example 48 Interleukin-1 receptor-associated kinase 4 Homo sapiens 691 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414471&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377375 433914529 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827415 COc1cc2nn(cc2cc1NC(=O)c1nc(C)no1)C1CCOCC1 InChI=1S/C17H19N5O4/c1-10-18-17(26-21-10)16(23)19-14-7-11-9-22(12-3-5-25-6-4-12)20-13(11)8-15(14)24-2/h7-9,12H,3-6H2,1-2H3,(H,19,23) CUVGVPBWROQOSI-UHFFFAOYSA-N 414472 N-[6-Methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-3-methyl-1,2,4-oxadiazole-5-carboxamide::US10435396, Example 49 Interleukin-1 receptor-associated kinase 4 Homo sapiens 3782 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414472&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377583 433914530 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827416 FC(F)(F)c1csc(n1)C(=O)Nc1cc2cn(nc2cc1Cl)C1CCOCC1 InChI=1S/C17H14ClF3N4O2S/c18-11-6-12-9(7-25(24-12)10-1-3-27-4-2-10)5-13(11)22-15(26)16-23-14(8-28-16)17(19,20)21/h5-8,10H,1-4H2,(H,22,26) ULQKVHOEMKCFEV-UHFFFAOYSA-N 414474 N-[6-Chloro-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-4-(trifluoromethyl)-1,3-thiazole-2-carboxamide::US10435396, Example 50 Interleukin-1 receptor-associated kinase 4 Homo sapiens 496 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414474&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377542 433914532 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827417 COc1cc2nn(cc2cc1NC(=O)c1ccn(n1)C(F)F)C1CCOCC1 InChI=1S/C18H19F2N5O3/c1-27-16-9-14-11(10-25(23-14)12-3-6-28-7-4-12)8-15(16)21-17(26)13-2-5-24(22-13)18(19)20/h2,5,8-10,12,18H,3-4,6-7H2,1H3,(H,21,26) JKPMOYHGWJVDBR-UHFFFAOYSA-N 414475 1-(Difluoromethyl)-N-[6-methoxy-2-(tetrahydro-2H-pyran-4-yl)-2H-indazol-5-yl]-1H-pyrazole-3-carboxamide::US10435396, Example 51 Interleukin-1 receptor-associated kinase 4 Homo sapiens 6.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414475&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377580 433914533 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827418 COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(CCC(C)(C)O)CC1 InChI=1S/C25H30F3N5O3/c1-24(2,35)9-12-32-10-7-17(8-11-32)33-15-16-13-20(21(36-3)14-19(16)31-33)30-23(34)18-5-4-6-22(29-18)25(26,27)28/h4-6,13-15,17,35H,7-12H2,1-3H3,(H,30,34) SASRTTPKDCHCMK-UHFFFAOYSA-N 414476 N-{2-[1-(3-Hydroxy-3-methylbutyl)piperidin-4-yl]-6-methoxy-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 52 Interleukin-1 receptor-associated kinase 4 Homo sapiens 1.000 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414476&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377297 433914534 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827419 NC(=O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCNCC1 InChI=1S/C20H19F3N6O2/c21-20(22,23)17-3-1-2-14(26-17)19(31)27-16-8-11-10-29(12-4-6-25-7-5-12)28-15(11)9-13(16)18(24)30/h1-3,8-10,12,25H,4-7H2,(H2,24,30)(H,27,31) YLLKPUGBVQPDBY-UHFFFAOYSA-N 414477 2-(Piperidin-4-yl)-5-({[6-(trifluoromethyl)pyridin-2-yl]carbonyl}amino)-2H-indazole-6-carboxamide::US10435396, Example 53 Interleukin-1 receptor-associated kinase 4 Homo sapiens 1.000 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414477&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377455 433914535 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827420 OC(=O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCNCC1 InChI=1S/C20H18F3N5O3/c21-20(22,23)17-3-1-2-14(25-17)18(29)26-16-8-11-10-28(12-4-6-24-7-5-12)27-15(11)9-13(16)19(30)31/h1-3,8-10,12,24H,4-7H2,(H,26,29)(H,30,31) MOSWJVTXDLVKPZ-UHFFFAOYSA-N 414478 2-(Piperidin-4-yl)-5-({[6-(trifluoromethyl)pyridin-2-yl]carbonyl}amino)-2H-indazole-6-carboxylic Acid::US10435396, Example 54 Interleukin-1 receptor-associated kinase 4 Homo sapiens 75.0 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414478&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377343 433914536 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827421 COC(=O)c1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(F)(F)F)C1CCN(C)CC1 InChI=1S/C22H22F3N5O3/c1-29-8-6-14(7-9-29)30-12-13-10-18(15(21(32)33-2)11-17(13)28-30)27-20(31)16-4-3-5-19(26-16)22(23,24)25/h3-5,10-12,14H,6-9H2,1-2H3,(H,27,31) LYDURIMSCWGUPX-UHFFFAOYSA-N 414479 Methyl 2-(1-methylpiperidin-4-yl)-5-({[6-(trifluoromethyl)pyridin-2-yl]carbonyl}amino)-2H-indazole-6-carboxylate::US10435396, Example 55 Interleukin-1 receptor-associated kinase 4 Homo sapiens 1.000 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414479&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377404 433914537 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827422 CC(C)(O)CCN1CCC(CC1)n1cc2cc(NC(=O)c3cccc(n3)C(F)(F)F)c(cc2n1)C(N)=O InChI=1S/C25H29F3N6O3/c1-24(2,37)8-11-33-9-6-16(7-10-33)34-14-15-12-20(17(22(29)35)13-19(15)32-34)31-23(36)18-4-3-5-21(30-18)25(26,27)28/h3-5,12-14,16,37H,6-11H2,1-2H3,(H2,29,35)(H,31,36) KQJGNHRGEMAORY-UHFFFAOYSA-N 414480 2-[1-(3-Hydroxy-3-methylbutyl)piperidin-4-yl]-5-({[6-(trifluoromethyl)pyridin-2-yl]carbonyl}amino)-2H-indazole-6-carboxamide::US10435396, Example 56 Interleukin-1 receptor-associated kinase 4 Homo sapiens 4.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414480&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377436 433914538 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827423 CN1CCC(CC1)n1cc2cc(NC(=O)c3cccc(n3)C(F)(F)F)c(cc2n1)C(N)=O InChI=1S/C21H21F3N6O2/c1-29-7-5-13(6-8-29)30-11-12-9-17(14(19(25)31)10-16(12)28-30)27-20(32)15-3-2-4-18(26-15)21(22,23)24/h2-4,9-11,13H,5-8H2,1H3,(H2,25,31)(H,27,32) GYZALJVTYLDNOY-UHFFFAOYSA-N 414481 2-(1-Methylpiperidin-4-yl)-5-({[6-(trifluoromethyl)pyridin-2-yl]carbonyl}amino)-2H-indazole-6-carboxamide::US10435396, Example 57 Interleukin-1 receptor-associated kinase 4 Homo sapiens 2.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414481&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377349 433914539 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589 827424 COCCN1CCC(CC1)n1cc2cc(NC(=O)c3cccc(n3)C(F)(F)F)c(OC)cc2n1 InChI=1S/C23H26F3N5O3/c1-33-11-10-30-8-6-16(7-9-30)31-14-15-12-19(20(34-2)13-18(15)29-31)28-22(32)17-4-3-5-21(27-17)23(24,25)26/h3-5,12-14,16H,6-11H2,1-2H3,(H,28,32) VOYWHAVHETZJEC-UHFFFAOYSA-N 414482 N-{6-Methoxy-2-[1-(2-methoxyethyl)piperidin-4-yl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide::US10435396, Example 58 Interleukin-1 receptor-associated kinase 4 Homo sapiens 2.00 US Patent 10.7270/Q28C9ZMZ aid1803856 US10435396 Bothe, U; Siebeneicher, H; Schmidt, N; Gunther, J; Steuber, H; Bomer, U; Lange, M; Nubbemeyer, R; Ray, NC; Savy, P 10/8/2019 8/16/2020 Bayer Pharma Aktiegesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414482&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search 137377382 433914540 1 MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 2NRU,2NRY,2O8Y,2OIB,2OIC,2OID,3MOP,4RMZ,4XS2,4Y73,4YO6,4YP8,4ZTL,4ZTM,4ZTN,5K72,5K75,5K76,5K7G,5K7I,5KX7,5KX8,5T1S,5T1T,5UIQ,5UIR,5UIS,5UIT,5UIU,6EG9,6EGA,6F3D,6F3E,6F3G,6F3I,6MOM,6N8G,6O8U,6O94,6O95,6O9D,6RFI,6RFJ,6THW,6THX,6THZ,6TI8,6TIA,6UYA,7C2V,7C2W,7QG1,7QG2,7QG3,7QG5,8DKS Interleukin-1 receptor-associated kinase 4 IRAK4_HUMAN Q9NWZ3 Q69FE1 Q8TDF7 Q9Y589